Key Dates

Related Announcements

RFA-CA-22-052 - Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01 Clinical Trial Not Allowed)

RFA-CA-22-053 - Coordinating Center for Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U24 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute's Division of Cancer Control and Population Sciences (DCCPS) will hold a pre-application webinar for RFA-CA-22-052 "Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01 Clinical Trial Not Allowed)" and RFA-CA-22-053 “Coordinating Center for Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U24 Clinical Trial Not Allowed).”

The pre-application webinar, to be held on Wednesday, October 26, 2022, from 3:30 pm - 4:30 pm ET, will include an overview of the two funding opportunity announcements (FOAs) as well as specific requirements for applications submitted in response to the FOAs. The webinar will conclude with an open question and answer session. Potential applicants are encouraged to submit their questions in advance to [email protected].

Note: Questions about the scope of the FOAs will be addressed during the webinar; however, questions about investigators' specific study aims will not be addressed in the webinar.

Registration for the webinar is required. Register at https://cbiit.webex.com/cbiit/j.php?RGID=r5f0736838c39202eff1d48ab012ec956.

Following this webinar, NCI DCCPS will link to a recording on https://epi.grants.cancer.gov/cannabis.

Inquiries

Please direct all inquiries to:

[email protected].